Whittier Trust’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,052
Closed -$73.2K 1565
2025
Q2
$73.2K Sell
3,052
-9,991
-77% -$232K ﹤0.01% 866
2025
Q1
$299K Buy
13,043
+967
+8% +$23.3K ﹤0.01% 573
2024
Q4
$306K Buy
12,076
+9,802
+431% +$248K ﹤0.01% 584
2024
Q3
$56.7K Buy
2,274
+1,518
+201% +$45K ﹤0.01% 901
2024
Q2
$22.4K Sell
756
-7,888
-91% -$219K ﹤0.01% 1075
2024
Q1
$261K Buy
8,644
+1,106
+15% +$30.7K ﹤0.01% 597
2023
Q4
$216K Buy
7,538
+1,141
+18% +$33.5K ﹤0.01% 633
2023
Q3
$237K Buy
6,397
+5,819
+1,007% +$222K ﹤0.01% 597
2023
Q2
$22.5K Hold
578
﹤0.01% 1098
2023
Q1
$21.1K Hold
578
﹤0.01% 1147
2022
Q4
$17.8K Buy
+578
New +$17.9K ﹤0.01% 1171

Other funds holding RTO

Whittier Trust's RTO Position: Q3 2025 in Review

Whittier Trust sold out of Rentokil (RTO) in Q3 2025, closing a stake of 3,052 shares — an estimated $73.2K sold.

Whittier Trust first reported a position in RTO in Q4 2022 and held it in 11 quarters. The position peaked at $306K in Q4 2024. 213 funds tracked by Wall St. Rank hold RTO as of Q3 2025.

  • Whittier Trust reported no remaining Rentokil position as of Q3 2025 after selling out during the quarter.
  • Whittier Trust sold 3,052 Rentokil shares in Q3 2025, an estimated $73.2K.
  • Whittier Trust first reported a position in Rentokil in Q4 2022 and held it in 11 quarters.
  • Whittier Trust's Rentokil position peaked at $306K in Q4 2024.
  • 213 funds tracked by Wall St. Rank held Rentokil as of Q3 2025.

Based on Whittier Trust's 13F filing for Q3 2025, filed 31 Oct 2025.